Single-use Bioreactors Market Size Analysis 2022 To 2030

The global single-use bioreactors market size accounted for US$ 3.95 Bn in 2021 and is projected to reach around USD 18.43 Bn by 2030, growing at a CAGR of 18.67% from 2022 to 2030.

Report Summary

The global single-use bioreactors market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the single-use bioreactors market across the globe.

A comprehensive estimate on the single-use bioreactors market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of single-use bioreactors during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2308

Single-use Bioreactors Market Report Scope 

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized single-use bioreactors market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Alumina Market Size Analysis 2022 To 2030

Market Players

The report includes the profiles of key single-use bioreactors market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area 

• ABEC Inc.
• Able Corporation & Biott Corporation (Japan)
• Applikon Biotechnology B.V.
• Aptus bioreactors.
• Cell culture company
• Cellexus Ltd
• Celltainer Biotech BV (Netherlands)
• CESCO Bioengineering Co., Ltd.
• Danaher Corporation
• Distek Inc. (US)
• ENDEL ENGIE
• Eppendorf AG (Germany)
• G&G Technologies Inc. (Australia)
• GE Healthcare
• Getinge AB (Sweden)
• GPC Bio
• Infors AG.
• Meissner Filtration Products Inc.
• Merck KgaA (Germany)
• New Horizon Biotechnology Inc.
• OmniBRx Biotechnologies
• Pall Corporation
• Parker-Hannifin Corporation,
• PBS Biotech Inc. (US)
• Pierre Guerin Technologies
• Sartorius Stedim Biotech (Germany)
• Satake Chemical Equipment Mfg., Ltd. (Japan)
• Solaris Biotechnology SRL
• Solida Biotech GmbH (Germany)
• Stobbe Pharma GmbH (Germany)
• Thermo Fisher Scientific (US)

Single-use Bioreactors Market  Segmentation

By Product 

• Single-use Bioreactor Systems
  • Up to 10L
  • 11-100L
  • 101-500L
  • 501-1500L
  • Above 1500L
• Single-use Media Bags
  • 2D Bags
  • 3D Bags
  • Others
• Single-use Filtration Assemblies
• Other Products

By Type

• Stirred-tank SUBs
• Bubble-column SUBs
• Wave-induced SUBs
• Other SUBs

By Type of Cell

• Mammalian Cells
• Yeast Cells
• Bacterial Cells
• Others

By Molecule Type

• Monoclonal Antibodies
• Vaccines
• Stem Cells
• Gene Modified Cells
• Others

By Application

• Research and Development (R&D) or Process Development
• Bioproduction

By End-Use

• CROs & CMOs
• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes

By Usage Type

• Pilot-scale Production
• Lab-scale Production
• Large-scale Production

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Single-use Bioreactors Market, By Product

7.1. Single-use Bioreactors Market, by Product, 2022-2030

7.1.1. Single-use Bioreactor Systems

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Single-use Media Bags

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Single-use Filtration Assemblies

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Other Products

7.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Single-use Bioreactors Market, By Type

8.1. Single-use Bioreactors Market, by Type, 2022-2030

8.1.1. Stirred-tank SUBs

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Bubble-column SUBs

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Wave-induced SUBs

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Other SUBs

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Single-use Bioreactors Market, By Type of Cell

9.1. Single-use Bioreactors Market, by Type of Cell, 2022-2030

9.1.1. Mammalian Cells

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Yeast Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Bacterial Cells

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Single-use Bioreactors Market, By Molecule Type

10.1. Single-use Bioreactors Market, by Molecule Type, 2022-2030

10.1.1. Monoclonal Antibodies

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Vaccines

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Stem Cells

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Gene Modified Cells

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Single-use Bioreactors Market, By Application

11.1. Single-use Bioreactors Market, by Application, 2022-2030

11.1.1. Research and Development (R&D) or Process Development

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Bioproduction

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Single-use Bioreactors Market, By End-Use

12.1. Single-use Bioreactors Market, by End-Use, 2022-2030

12.1.1. CROs & CMOs

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Pharmaceutical & Biopharmaceutical Companies

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Single-use Bioreactors Market, By Usage Type

13.1. Single-use Bioreactors Market, by Usage Type, 2022-2030

13.1.1. Pilot-scale Production

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Lab-scale Production

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Large-scale Production

13.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Single-use Bioreactors Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

Chapter 15. Company Profiles

15.1. ABEC Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Able Corporation & Biott Corporation (Japan)

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Applikon Biotechnology B.V.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Aptus bioreactors.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5 Cell culture company

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Cellexus Ltd

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Celltainer Biotech BV (Netherlands)

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. CESCO Bioengineering Co., Ltd.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Danaher Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Distek Inc. (US)

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com